igella sativa in hemodialysis
Phase 3
- Conditions
- E00–E90Diabetic patients undergoing hemodialysis.Endocrine, nutritional and metabolic diseases
- Registration Number
- IRCT20200411047027N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Age: 18-60
BMI: 18.5-30
Diabetes
At least 6 months of dialysis history
maximum 10 years of dialysis history
Ability and willingness to cooperate
Exclusion Criteria
Background diseases (heart failure stage 3 and 4, acute liver and thyroid disease, malignancy)
nigella sativa oil consumption before entering the study
Alcohol addiction, smoking
receiving steroidal or nonsteroidal anti-inflammatory drugs
sever reaction to supplement or placebo
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method